Antimicrobial peptides: key components of the innate immune system

References

• Adessi C, Soto C. (2002). Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem, 9, 963–978.
   PubMed Web of Science ®Google Scholar
• Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jörnvall H, Wigzell H, Gudmundsson GH. (2000). The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood, 96, 3086–3093.
   PubMed Web of Science ®Google Scholar
• Andersson DI, Hughes D. (2010). Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol, 8, 260–271.
   PubMed Web of Science ®Google Scholar
• Andersson E, Rydengård V, Sonesson A, Mörgelin M, Björck L, Schmidtchen A. (2004). Antimicrobial activities of heparin-binding peptides. Eur J Biochem, 271, 1219–1226.
   PubMedGoogle Scholar
• Angelova A, Ionov R, Koch MH, Rapp G. (2000). Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. Arch Biochem Biophys, 378, 93–106.
   PubMed Web of Science ®Google Scholar
• Auvynet C, Rosenstein Y. (2009). Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J, 276, 6497–6508.
   PubMed Web of Science ®Google Scholar
• Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. (2000). Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol, 1, 113–118.
   PubMed Web of Science ®Google Scholar
• Ayoub M, Scheidegger D. (2006). Peptide drugs, overcoming the challenges, a growing business. Chimica Oggi-Chemistry Today, 24, 46–48.
   Web of Science ®Google Scholar
• Badria FA, Guirguis AN, Perovic S, Steffen R, Muller WE, Schroder HC. (1998). Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum. Toxicology, 131, 133–143.
   PubMed Web of Science ®Google Scholar
• Bals R, Goldman MJ, Wilson JM. (1998a). Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun, 66, 1225–1232.
   PubMed Web of Science ®Google Scholar
• Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM. (1998b). Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest, 102, 874–880.
   PubMed Web of Science ®Google Scholar
• Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM. (1999a). Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun, 67, 6084–6089.
   PubMed Web of Science ®Google Scholar
• Bals R, Weiner DJ, Wilson JM. (1999b). The innate immune system in cystic fibrosis lung disease. J Clin Invest, 103, 303–307.
   PubMed Web of Science ®Google Scholar
• Bals R, Lang C, Weiner DJ, Vogelmeier C, Welsch U, Wilson JM. (2001). Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin Diagn Lab Immunol, 8, 370–375.
   PubMedGoogle Scholar
• Banerjee A, Pramanik A, Bhattacharjya S, Balaram P. (1996). Omega amino acids in peptide design: incorporation into helices. Biopolymers, 39, 769–777.
   PubMed Web of Science ®Google Scholar
• Bessalle R, Gorea A, Shalit I, Metzger JW, Dass C, Desiderio DM, Fridkin M. (1993). Structure-function studies of amphiphilic antibacterial peptides. J Med Chem, 36, 1203–1209.
   PubMed Web of Science ®Google Scholar
• Bhonsle JB, Venugopal D, Huddler DP, Magill AJ, Hicks RP. (2007). Application of 3D-QSAR for identification of descriptors defining bioactivity of antimicrobial peptides. J Med Chem, 50, 6545–6553.
   PubMed Web of Science ®Google Scholar
• Bhutia SK, Maiti TK. (2008). Targeting tumors with peptides from natural sources. Trends Biotechnol, 26, 210–217.
   PubMed Web of Science ®Google Scholar
• Biggs JS, Rosenfeld Y, Shai Y, Olivera BM. (2007). Conolysin-Mt: a conus peptide that disrupts cellular membranes. Biochemistry, 46, 12586–12593.
   PubMed Web of Science ®Google Scholar
• Blondelle SE, Houghten RA. (1992). Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry, 31, 12688–12694.
   PubMed Web of Science ®Google Scholar
• Bochud PY, Bochud M, Telenti A, Calandra T. (2007). Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect Dis, 7, 531–542.
   PubMed Web of Science ®Google Scholar
• Boman HG, Nilsson I, Rasmuson B. (1972). Inducible antibacterial defence system in Drosophila. Nature, 237, 232–235.
   PubMed Web of Science ®Google Scholar
• Boman HG. (1981). in Microbial Control of Insects, Mites and Plant Diseases. New York: Academic. 769–784.
   Google Scholar
• Boman HG, Agerberth B, Boman A. (1993). Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun, 61, 2978–2984.
   PubMed Web of Science ®Google Scholar
• Boman HG. (1995). Peptide antibiotics and their role in innate immunity. Annu Rev Immunol, 13, 61–92.
   PubMed Web of Science ®Google Scholar
• Boman HG. (2000). Innate immunity and the normal microflora. Immunol Rev, 173, 5–16.
   PubMed Web of Science ®Google Scholar
• Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock RE, Kalman D. (2010). Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides, 31, 1957–1965.
   PubMed Web of Science ®Google Scholar
• Bonsen PP, de Haas GH, van Deenen LL. (1967). Synthetic and structural investigations on 3-phosphatidyl-1′-(3′-O-L-lysyl)glycerol. Biochemistry, 6, 1114–1120.
   PubMed Web of Science ®Google Scholar
• Bowdish DM, Davidson DJ, Hancock RE. (2005a). A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci, 6, 35–51.
   PubMed Web of Science ®Google Scholar
• Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. (2005b). Impact of LL-37 on anti-infective immunity. J Leukoc Biol, 77, 451–459.
   PubMed Web of Science ®Google Scholar
• Bowdish DM, Davidson DJ, Scott MG, Hancock RE. (2005c). Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother, 49, 1727–1732.
   PubMed Web of Science ®Google Scholar
• Bowdish DM, Davidson DJ, Hancock RE. (2006). Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol, 306, 27–66.
   PubMed Web of Science ®Google Scholar
• Brogden KA, Ackermann M, McCray PB, Jr., Tack BF. (2003a). Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents, 22, 465–478.
   PubMed Web of Science ®Google Scholar
• Brogden KA, Heidari M, Sacco RE, Palmquist D, Guthmiller JM, Johnson GK, Jia HP, Tack BF, McCray PB. (2003b). Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol, 18, 95–99.
   PubMedGoogle Scholar
• Brumfitt W, Salton MR, Hamilton-Miller JM. (2002). Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother, 50, 731–734.
   PubMed Web of Science ®Google Scholar
• Bucki R, Leszczynska K, Namiot A, Sokolowski W. (2010). Cathelicidin LL-37: a multitask antimicrobial peptide. Arch Immunol Ther Exp (Warsz), 58, 15–25.
   PubMed Web of Science ®Google Scholar
• Campese M, Sun X, Bosch JA, Oppenheim FG, Helmerhorst EJ. (2009). Concentration and fate of histatins and acidic proline-rich proteins in the oral environment. Arch Oral Biol, 54, 345–353.
   PubMed Web of Science ®Google Scholar
• Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. (2002). Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA, 99, 3902–3907.
   PubMed Web of Science ®Google Scholar
• Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Qiao DR. (2010). Design, Recombinant Expression, and Antibacterial Activity of the Cecropins-Melittin Hybrid Antimicrobial Peptides. Curr Microbiol, 61, 169–175.
   PubMed Web of Science ®Google Scholar
• Carlsson A, Engstrom P, Palva ET, Bennich H. (1991). Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription. Infect Immun, 59, 3040–3045.
   PubMed Web of Science ®Google Scholar
• Cassone M, Otvos L Jr. (2010). Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev Anti Infect Ther, 8, 703–716.
   PubMed Web of Science ®Google Scholar
• Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J. (2004). Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res, 64, 2382–2389.
   PubMed Web of Science ®Google Scholar
• Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P. (1996). Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J Biol Chem, 271, 21808–21813.
   Google Scholar
• Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C, Gu L, Fiddes JC. (2000). Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers, 55, 88–98.
   PubMed Web of Science ®Google Scholar
• Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H. (2005). Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci, 40, 123–132.
   PubMed Web of Science ®Google Scholar
• Chen X, Niyonsaba F, Ushio H, Hara M, Yokoi H, Matsumoto K, Saito H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. (2007). Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol, 37, 434–444.
   PubMed Web of Science ®Google Scholar
• Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. (1996). Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem, 271, 2935–2940.
   PubMed Web of Science ®Google Scholar
• Cho JH, Park CB, Yoon YG, Kim SC. (1998a). Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. Biochim Biophys Acta, 1408, 67–76.
   PubMed Web of Science ®Google Scholar
• Cho Y, Turner JS, Dinh NN, Lehrer RI. (1998b). Activity of protegrins against yeast-phase Candida albicans. Infect Immun, 66, 2486–2493.
   PubMed Web of Science ®Google Scholar
• Chu KT, Ng TB. (2003). Isolation of a large thaumatin-like antifungal protein from seeds of the Kweilin chestnut Castanopsis chinensis. Biochem Biophys Res Commun, 301, 364–370.
   PubMed Web of Science ®Google Scholar
• Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D’Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G. (2004). Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. J Infect Dis, 190, 356–364.
   PubMed Web of Science ®Google Scholar
• Cole AM, Weis P, Diamond G. (1997). Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem, 272, 12008–12013.
   PubMed Web of Science ®Google Scholar
• Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, Bristol G, Zack JA, Waring AJ, Yang OO, Lehrer RI. (2002). Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A, 99, 1813–1818.
   PubMed Web of Science ®Google Scholar
• Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. (2000). Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood, 95, 543–550.
   PubMed Web of Science ®Google Scholar
• Costa MM, Dios S, Alonso-Gutierrez J, Romero A, Novoa B, Figueras A. (2009). Evidence of high individual diversity on myticin C in mussel (Mytilus galloprovincialis). Dev Comp Immunol, 33, 162–170.
   PubMed Web of Science ®Google Scholar
• Cronan JE. (2003). Bacterial membrane lipids: where do we stand? Annu Rev Microbiol, 57, 203–224.
   PubMed Web of Science ®Google Scholar
• Daher KA, Selsted ME, Lehrer RI. (1986). Direct inactivation of viruses by human granulocyte defensins. J Virol, 60, 1068–1074.
   PubMed Web of Science ®Google Scholar
• Darmoul D, Ouellette AJ. (1996). Positional specificity of defensin gene expression reveals Paneth cell heterogeneity in mouse small intestine. Am J Physiol, 271, 68–74.
   PubMed Web of Science ®Google Scholar
• Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, Bienert M. (1997). Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett, 403, 208–212.
   PubMed Web of Science ®Google Scholar
• Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M. (2001). Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett, 501, 146–150.
   PubMed Web of Science ®Google Scholar
• Dathe M, Meyer J, Beyermann M, Maul B, Hoischen C, Bienert M. (2002). General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim Biophys Acta, 1558, 171–186.
   PubMed Web of Science ®Google Scholar
• Dathe M, Nikolenko H, Klose J, Bienert M. (2004). Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides. Biochemistry, 43, 9140–9150.
   PubMed Web of Science ®Google Scholar
• de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W. (2006). Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun, 74, 5284–5291.
   PubMed Web of Science ®Google Scholar
• De Lucca AJ, Bland JM, Grimm C, Jacks TJ, Cary JW, Jaynes JM, Cleveland TE, Walsh TJ. (1998a). Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. Can J Microbiol, 44, 514–520.
   PubMed Web of Science ®Google Scholar
• De Lucca AJ, Bland JM, Jacks TJ, Grimm C, Walsh TJ. (1998b). Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. Med Mycol, 36, 291–298.
   PubMed Web of Science ®Google Scholar
• De Lucca AJ, Cleveland TE, Wedge DE. (2005). Plant-derived antifungal proteins and peptides. Can J Microbiol, 51, 1001–1014.
   PubMed Web of Science ®Google Scholar
• De Smet K, Contreras R. (2005). Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett, 27, 1337–1347.
   PubMed Web of Science ®Google Scholar
• Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, Damico LA. (2002). Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem, 277, 35035–35043.
   PubMed Web of Science ®Google Scholar
• Dennison SR, Harris F, Phoenix DA. (2005a). Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion? Protein Pept Lett, 12, 27–29.
   PubMed Web of Science ®Google Scholar
• Dennison SR, Wallace J, Harris F, Phoenix DA. (2005b). Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. Protein Pept Lett, 12, 31–39.
   PubMed Web of Science ®Google Scholar
• Destoumieux D, Munoz M, Bulet P, Bachere E. (2000). Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda). Cell Mol Life Sci, 57, 1260–1271.
   PubMed Web of Science ®Google Scholar
• Dobrzynska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z. (2005). Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem, 276, 113–119.
   PubMed Web of Science ®Google Scholar
• Dodd GT, Mancini G, Lutz B, Luckman SM. (2010). The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice. J Neurosci, 30, 7369–7376.
   PubMed Web of Science ®Google Scholar
• Donate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP. (2004). Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res, 64, 5812–5817.
   PubMed Web of Science ®Google Scholar
• Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL. (2006). The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. Faseb J, 20, 35–42.
   PubMed Web of Science ®Google Scholar
• Dos Santos Cabrera MP, Arcisio-Miranda M, da Costa LC, de Souza BM, Broggio Costa ST, Palma MS, Ruggiero Neto J, Procopio J. (2009). Interactions of mast cell degranulating peptides with model membranes: a comparative biophysical study. Arch Biochem Biophys, 486, 1–11.
   PubMed Web of Science ®Google Scholar
• Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH. (2002). Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology, 106, 517–525.
   PubMed Web of Science ®Google Scholar
• Durr UH, Sudheendra US, Ramamoorthy A. (2006). LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta, 1758, 1408–1425.
   PubMed Web of Science ®Google Scholar
• Dyer KD, Rosenberg HF. (2006). The RNase a superfamily: generation of diversity and innate host defense. Mol Divers, 10, 585–597.
   PubMed Web of Science ®Google Scholar
• Ehrenstein G, Lecar H. (1977). Electrically gated ionic channels in lipid bilayers. Q Rev Biophys, 10, 1–34.
   PubMed Web of Science ®Google Scholar
• Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P. (1996). Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood. J Biol Chem, 271, 29537–29544.
   PubMed Web of Science ®Google Scholar
• El Jastimi R, Lafleur M. (1999). Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamines. Biochim Biophys Acta, 1418, 97–105.
   PubMed Web of Science ®Google Scholar
• Elsbach P. (1990). Antibiotics from within: antibacterials from human and animal sources. Trends Biotechnol, 8, 26–30.
   PubMed Web of Science ®Google Scholar
• Epand RF, Epand RM, Monaco V, Stoia S, Formaggio F, Crisma M, Toniolo C. (1999). The antimicrobial peptide trichogin and its interaction with phospholipid membranes. Eur J Biochem, 266, 1021–1028.
   PubMedGoogle Scholar
• Epand RF, Maloy L, Ramamoorthy A, Epand RM. (2010). Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline States in the presence of phosphatidylglycerol: lipid clustering in anionic membranes. Biophys J, 98, 2564–2573.
   PubMed Web of Science ®Google Scholar
• Epand RM, Epand RF. (2009). Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta, 1788, 289–294.
   PubMed Web of Science ®Google Scholar
• Fernandes JM, Kemp GD, Molle MG, Smith VJ. (2002). Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. Biochem J, 368, 611–620.
   PubMed Web of Science ®Google Scholar
• Frecer V, Ho B, Ding JL. (2004). De novo design of potent antimicrobial peptides. Antimicrob Agents Chemother, 48, 3349–3357.
   PubMed Web of Science ®Google Scholar
• Frecer V. (2006). QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1. Bioorg Med Chem, 14, 6065–6074.
   PubMed Web of Science ®Google Scholar
• Frick IM, Akesson P, Herwald H, Morgelin M, Malmsten M, Nagler DK, Bjorck L. (2006). The contact system–a novel branch of innate immunity generating antibacterial peptides. Embo J, 25, 5569–5578.
   PubMed Web of Science ®Google Scholar
• Fritz JH, Brunner S, Birnstiel ML, Buschle M, Gabain A, Mattner F, Zauner W. (2004). The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine, 22, 3274–3284.
   PubMed Web of Science ®Google Scholar
• Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, Gudmundsson GH. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem, 272, 15258–15263.
   PubMed Web of Science ®Google Scholar
• Galgóczy L, Kovács L, CS V. (2010). Defensin-like antifungal proteins secreted by filamentous fungi. Current Research, Technology and Education. Topics in Applied Microbiology and. Microbial Biotechnology. Available at http://www.formatex.info/microbiology2/550–559.pdf
   Google Scholar
• Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. (1985). Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest, 76, 1427–1435.
   PubMed Web of Science ®Google Scholar
• Ganz T, Lehrer RI. (1994). Defensins. Curr Opin Immunol, 6, 584–589.
   PubMed Web of Science ®Google Scholar
• Ganz T, Lehrer RI. (1995). Defensins. Pharmacol Ther, 66, 191–205.
   PubMed Web of Science ®Google Scholar
• Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME. (2008). Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun, 76, 5883–5891.
   PubMed Web of Science ®Google Scholar
• Garlapati S, Facci M, Polewicz M, Strom S, Babiuk LA, Mutwiri G, Hancock RE, Elliott MR, Gerdts V. (2009). Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet Immunol Immunopathol, 128, 184–191.
   PubMed Web of Science ®Google Scholar
• Gazit E, Bach D, Kerr ID, Sansom MS, Chejanovsky N, Shai Y. (1994). The alpha-5 segment of Bacillus thuringiensis delta-endotoxin: in vitro activity, ion channel formation and molecular modelling. Biochem J, 304, 895–902.
   PubMed Web of Science ®Google Scholar
• Gesell J, Zasloff M, Opella SJ. (1997). Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J Biomol NMR, 9, 127–135.
   PubMed Web of Science ®Google Scholar
• Giangaspero A, Sandri L, Tossi A. (2001). Amphipathic alpha helical antimicrobial peptides. Eur J Biochem, 268, 5589–5600.
   PubMedGoogle Scholar
• Gifford JL, Hunter HN, Vogel HJ. (2005). Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci, 62, 2588–2598.
   PubMed Web of Science ®Google Scholar
• Gimenez D, Andreu C, del Olmo M, Varea T, Diaz D, Asensio G. (2006). The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity. Bioorg Med Chem, 14, 6971–6978.
   PubMed Web of Science ®Google Scholar
• Giuliani A, Pirri G, Nicoletto SF. (2007). Antimicrobial peptides: an overview of a promising class of therapeutics. Central European Journal of Biology 2, 1–33.
   Web of Science ®Google Scholar
• Glukhov E, Stark M, Burrows LL, Deber CM. (2005). Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem, 280, 33960–33967.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Chavez SA, Arevalo-Gallegos S, Rascon-Cruz Q. (2009). Lactoferrin: structure, function and applications. Int J Antimicrob Agents, 33, 301 e1-8.
   PubMed Web of Science ®Google Scholar
• Goodman M, Zapf C, Rew Y. (2001). New reagents, reactions, and peptidomimetics for drug design. Biopolymers, 60, 229–245.
   PubMed Web of Science ®Google Scholar
• Gordon YJ, Romanowski EG, McDermott AM. (2005). A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res, 30, 505–515.
   PubMed Web of Science ®Google Scholar
• Grutkoski PS, Graeber CT, Lim YP, Ayala A, Simms HH. (2003). Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes. Antimicrob Agents Chemother, 47, 2666–2668.
   PubMed Web of Science ®Google Scholar
• Gueguen Y, Bernard R, Julie F, Paulina S, Delphine DG, Franck V, Philippe B, Evelyne B. (2009). Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin. Mol Immunol, 46, 516–522.
   PubMed Web of Science ®Google Scholar
• Guichard G, Benkirane N, Zeder-Lutz G, van Regenmortel MH, Briand JP, Muller S. (1994). Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc Natl Acad Sci U S A, 91, 9765–9769.
   PubMed Web of Science ®Google Scholar
• Gunn JS, Ryan SS, Van Velkinburgh JC, Ernst RK, Miller SI. (2000). Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun, 68, 6139–6146.
   PubMed Web of Science ®Google Scholar
• Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI. (1998). Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell, 95, 189–198.
   PubMed Web of Science ®Google Scholar
• Haest CW, de Gier J, den Kamp JO, Bartels P, van Deenen LL. (1972). Chages in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. Biochim Biophys Acta, 255, 720–733.
   PubMed Web of Science ®Google Scholar
• Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM. (2008). Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis, 198, 125–133.
   Google Scholar
• Hale JD, Hancock RE. (2007). Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther, 5, 951–959.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Lehrer R. (1998). Cationic peptides: a new source of antibiotics. Trends Biotechnol, 16, 82–88.
   PubMed Web of Science ®Google Scholar
• Hancock RE. (2000). Cationic antimicrobial peptides: towards clinical applications. Expert Opin Investig Drugs, 9, 1723–1729.
   PubMed Web of Science ®Google Scholar
• Hancock RE. (2001). Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis, 1, 156–164.
   PubMedGoogle Scholar
• Hancock RE, Rozek A. (2002). Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett, 206, 143–149.
   PubMed Web of Science ®Google Scholar
• Hancock RE. (2005). Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect Dis, 5, 209–218.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol, 24, 1551–1557.
   PubMed Web of Science ®Google Scholar
• Hancock RE. (2007). The complexities of antibiotic action. Mol Syst Biol, 3, 142.
   PubMed Web of Science ®Google Scholar
• Harder J, Schroder JM. (2002). RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem, 277, 46779–46784.
   PubMed Web of Science ®Google Scholar
• Harris F, Dennison SR, Phoenix DA. (2009). Anionic antimicrobial peptides from eukaryotic organisms. Curr Protein Pept Sci, 10, 585–606.
   PubMed Web of Science ®Google Scholar
• Haupt H, Heimburger N. (1972). Human serum proteins with high affinity for carboxymethylcellulose. I. Isolation of lysozyme, C1q and 2 hitherto unknown -globulins. Hoppe Seylers Z Physiol Chem, 353, 1125–1132.
   PubMedGoogle Scholar
• Hazlett L, Wu M. (2011). Defensins in innate immunity. Cell Tissue Res, 343, 175–188.
   PubMed Web of Science ®Google Scholar
• He J, Yarbrough DK, Kreth J, Anderson MH, Shi W, Eckert R. (2010). Systematic approach to optimizing specifically targeted antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother, 54, 2143–2151.
   PubMed Web of Science ®Google Scholar
• Heimburger N, Haupt H, Kranz T, Baudner S. (1972). Human serum proteins with high affinity to carboxymethylcellulose. II. Physico-chemical and immunological characterization of a histidine-rich 3,8S- 2 -glycoportein (CM-protein I). Hoppe Seylers Z Physiol Chem, 353, 1133–1140.
   Google Scholar
• Heinzelmann M, Mercer-Jones MA, Flodgaard H, Miller FN. (1998). Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation. J Immunol, 160, 5530–5536.
   PubMed Web of Science ®Google Scholar
• Heinzelmann M, Kim E, Hofmeister A, Gordon LE, Platz A, Cheadle WG. (2001). Heparin binding protein (CAP37) differentially modulates endotoxin-induced cytokine production. Int J Surg Investig, 2, 457–466.
   PubMedGoogle Scholar
• Hilpert K, Fjell CD, Cherkasov A. (2008). Short linear cationic antimicrobial peptides: screening, optimizing, and prediction. Methods Mol Biol, 494, 127–159.
   PubMedGoogle Scholar
• Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. (1999). Phylogenetic perspectives in innate immunity. Science, 284, 1313–1318.
   PubMed Web of Science ®Google Scholar
• Hoskin DW, Ramamoorthy A. (2008). Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta, 1778, 357–375.
   PubMed Web of Science ®Google Scholar
• Houston ME, Jr., Kondejewski LH, Karunaratne DN, Gough M, Fidai S, Hodges RS, Hancock RE. (1998). Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J Pept Res, 52, 81–88.
   PubMedGoogle Scholar
• Huang HW. (2006). Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta, 1758, 1292–1302.
   PubMed Web of Science ®Google Scholar
• Huang HW. (2009). Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys J, 96, 3263–3272.
   PubMed Web of Science ®Google Scholar
• Hughes AL. (1999). Evolutionary diversification of the mammalian defensins. Cell Mol Life Sci, 56, 94–103.
   PubMed Web of Science ®Google Scholar
• Hugli TE. (1990). Structure and function of C3a anaphylatoxin. Curr Top Microbiol Immunol, 153, 181–208.
   PubMed Web of Science ®Google Scholar
• Hultmark D, Steiner H, Rasmuson T, Boman HG. (1980). Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem, 106, 7–16.
   Google Scholar
• Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H. (1999). Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa. Arch Insect Biochem Physiol, 40, 88–98.
   PubMed Web of Science ®Google Scholar
• Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, Cowell SM, Becker CL, McLaughlin ML. (1996). De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem, 39, 3107–3113.
   PubMed Web of Science ®Google Scholar
• Jenssen H, Hamill P, Hancock RE. (2006). Peptide antimicrobial agents. Clin Microbiol Rev, 19, 491–511.
   PubMed Web of Science ®Google Scholar
• Jenssen H, Fjell CD, Cherkasov A, Hancock RE. (2008). QSAR modeling and computer-aided design of antimicrobial peptides. J Pept Sci, 14, 110–114.
   PubMed Web of Science ®Google Scholar
• Jeong N, Kim JY, Park SC, Lee JK, Gopal R, Yoo S, Son BK, Hahm JS, Park Y, Hahm KS. (2010). Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis. Biochem Biophys Res Commun, 399, 581–586.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Kullberg BJ, van der Lee H, Vasil AI, Hale JD, Mant CT, Hancock RE, Vasil ML, Netea MG, Hodges RS. (2008). Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides. Chem Biol Drug Des, 72, 483–495.
   PubMed Web of Science ®Google Scholar
• Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. (1998). Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem, 273, 3718–3724.
   PubMed Web of Science ®Google Scholar
• Jones AL, Hulett MD, Parish CR. (2005a). Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol, 83, 106–118.
   PubMed Web of Science ®Google Scholar
• Jones AL, Poon IK, Hulett MD, Parish CR. (2005b). Histidine-rich glycoprotein specifically binds to necrotic cells via its amino-terminal domain and facilitates necrotic cell phagocytosis. J Biol Chem, 280, 35733–35741.
   PubMed Web of Science ®Google Scholar
• Jones DE, Bevins CL. (1993). Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett, 315, 187–192.
   PubMed Web of Science ®Google Scholar
• Jung S, Dingley AJ, Augustin R, Anton-Erxleben F, Stanisak M, Gelhaus C, Gutsmann T, Hammer MU, Podschun R, Bonvin AM, Leippe M, Bosch TC, Grotzinger J. (2009). Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra. J Biol Chem, 284, 1896–1905.
   Google Scholar
• Juretic D, Vukicevic D, Petrov D, Novkovic M, Bojovic V, Lucic B, Ilic N, Tossi A. (2011). Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides. Eur Biophys J, 40, 371–385.
   PubMed Web of Science ®Google Scholar
• Kacprzyk L, Rydengard V, Morgelin M, Davoudi M, Pasupuleti M, Malmsten M, Schmidtchen A. (2007). Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta, 1768, 2667–2680.
   PubMed Web of Science ®Google Scholar
• Kavanagh K, Dowd S. (2004). Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol, 56, 285–289.
   PubMed Web of Science ®Google Scholar
• Khandelia H, Ipsen JH, Mouritsen OG. (2008). The impact of peptides on lipid membranes. Biochim Biophys Acta, 1778, 1528–1536.
   PubMed Web of Science ®Google Scholar
• Kieber-Emmons T, Murali R, Greene MI. (1997). Therapeutic peptides and peptidomimetics. Curr Opin Biotechnol, 8, 435–441.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jung JR, Lee SY, Chang IH, Lee TJ, Kim W, Myung SC. (2011). Expression of human beta-defensin-2 in the prostate. BJU Int, 107, 144–149.
   PubMed Web of Science ®Google Scholar
• Kim JM, Jang SA, Yu BJ, Sung BH, Cho JH, Kim SC. (2008). High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol, 78, 123–130.
   PubMed Web of Science ®Google Scholar
• Kim TH, Lee H, Park TG. (2002). Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials, 23, 2311–2317.
   PubMed Web of Science ®Google Scholar
• Kindrachuk J, Jenssen H, Elliott M, Townsend R, Nijnik A, Lee SF, Gerdts V, Babiuk LA, Halperin SA, Hancock RE. (2009). A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine, 27, 4662–4671.
   PubMed Web of Science ®Google Scholar
• Kjeldsen T, Pettersson AF, Drube L, Kurtzhals P, Jonassen I, Havelund S, Hansen PH, Markussen J. (1998). Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue. Protein Expr Purif, 13, 163–169.
   PubMed Web of Science ®Google Scholar
• Kluver E, Schulz-Maronde S, Scheid S, Meyer B, Forssmann WG, Adermann K. (2005). Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry, 44, 9804–9816.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Ohta N, Umeda M. (2004). Biology of lysenin, a protein in the coelomic fluid of the earthworm Eisenia foetida. Int Rev Cytol, 236, 45–99.
   PubMedGoogle Scholar
• Koczulla AR, Bals R. (2003). Antimicrobial peptides: current status and therapeutic potential. Drugs, 63, 389–406.
   PubMed Web of Science ®Google Scholar
• Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest, 111, 1665–1672.
   PubMed Web of Science ®Google Scholar
• Koehler MF, Zobel K, Beresini MH, Caris LD, Combs D, Paasch BD, Lazarus RA. (2002). Albumin affinity tags increase peptide half-life in vivo. Bioorg Med Chem Lett, 12, 2883–2886.
   PubMed Web of Science ®Google Scholar
• Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett, 327, 231–236.
   PubMed Web of Science ®Google Scholar
• Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock RE, Babiuk LA, van Drunen Littel-van den Hurk S. (2009). The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. Vaccine, 27, 2055–2064.
   PubMed Web of Science ®Google Scholar
• Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, Otvos L Jr. (2001). The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry, 40, 3016–3026.
   PubMed Web of Science ®Google Scholar
• Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W. (2002). Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). J Biol Chem, 277, 11208–11216.
   PubMed Web of Science ®Google Scholar
• Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, Otto M. (2007). The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol, 63, 497–506.
   PubMed Web of Science ®Google Scholar
• Lai Y, Gallo RL. (2009). AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol, 30, 131–141.
   PubMed Web of Science ®Google Scholar
• Langham AA, Khandelia H, Schuster B, Waring AJ, Lehrer RI, Kaznessis YN. (2008). Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Peptides, 29, 1085–1093.
   PubMed Web of Science ®Google Scholar
• Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. (1995). Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun, 63, 1291–1297.
   PubMed Web of Science ®Google Scholar
• Lax R, Michael V. (2006). Are low-priced peptides affordable? Chimica oggi 24, 38–40.
   Google Scholar
• Lee HS, Park CB, Kim JM, Jang SA, Park IY, Kim MS, Cho JH, Kim SC. (2008). Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett, 271, 47–55.
   PubMed Web of Science ®Google Scholar
• Lehrer RI, Lichtenstein AK, Ganz T. (1993). Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol, 11, 105–128.
   PubMed Web of Science ®Google Scholar
• Lehrer RI, Ganz T. (2002). Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol, 9, 18–22.
   PubMed Web of Science ®Google Scholar
• Lejon T, Stiberg T, Strom MB, Svendsen JS. (2004). Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. J Pept Sci, 10, 329–335.
   PubMed Web of Science ®Google Scholar
• Li C, Haug T, Styrvold OB, Jorgensen TO, Stensvag K. (2008). Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev Comp Immunol, 32, 1430–1440.
   PubMed Web of Science ®Google Scholar
• Li JF, Zhang J, Zhang Z, Ma HW, Zhang JX, Zhang SQ. (2010). Production of Bioactive Human Beta-Defensin-4 in Escherichia coli using SUMO Fusion Partner. Protein J, 29, 314–319.
   PubMed Web of Science ®Google Scholar
• Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. (2007a). The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol, 66, 1136–1147.
   PubMed Web of Science ®Google Scholar
• Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. (2007b). Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A, 104, 9469–9474.
   PubMed Web of Science ®Google Scholar
• Lien S, Lowman HB. (2003). Therapeutic peptides. Trends Biotechnol, 21, 556–562.
   PubMed Web of Science ®Google Scholar
• Lin KH, Chuang YC, Lee SH, Yu WL. (2010). In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae. J Microbiol Immunol Infect, 43, 317–322.
   PubMedGoogle Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 46, 3–26.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhao C, Heng HH, Ganz T. (1997). The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics, 43, 316–320.
   PubMed Web of Science ®Google Scholar
• Liu YQ, Sun ZJ, Wang C, Li SJ, Liu YZ. (2004). Purification of a novel antibacterial short peptide in earthworm Eisenia foetida. Acta Biochim Biophys Sin (Shanghai), 36, 297–302.
   PubMed Web of Science ®Google Scholar
• Lohner K, Sevcsik E, Pabst G. (2008). Liposome-based biomembrane mimetic systems: Implications for lipid-peptide interactions. Ed. by A L-L. Amsterdam: Elsevier.
   Google Scholar
• Ludtke S, He K, Huang H. (1995). Membrane thinning caused by magainin 2. Biochemistry, 34, 16764–16769.
   PubMed Web of Science ®Google Scholar
• Lugtenberg EJ, Peters R. (1976). Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12. Biochim Biophys Acta, 441, 38–47.
   PubMed Web of Science ®Google Scholar
• Luque-Ortega JR, van’t Hof W, Veerman EC, Saugar JM, Rivas L. (2008). Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. Faseb J, 22, 1817–1828.
   PubMed Web of Science ®Google Scholar
• Ma DY, Liu SW, Han ZX, Li YJ, Shan AS. (2008). Expression and characterization of recombinant gallinacin-9 and gallinacin-8 in Escherichia coli. Protein Expr Purif, 58, 284–291.
   PubMed Web of Science ®Google Scholar
• Maisetta G, Di Luca M, Esin S, Florio W, Brancatisano FL, Bottai D, Campa M, Batoni G. (2008). Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides, 29, 1–6.
   Google Scholar
• Makovitzki A, Shai Y. (2005). pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry, 44, 9775–9784.
   PubMed Web of Science ®Google Scholar
• Malm J, Sorensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A, Lilja H, Stahle-Backdahl M, Borregaard N, Egesten A. (2000). The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun, 68, 4297–4302.
   PubMed Web of Science ®Google Scholar
• Malmsten M, Davoudi M, Walse B, Rydengard V, Pasupuleti M, Morgelin M, Schmidtchen A. (2007). Antimicrobial peptides derived from growth factors. Growth Factors, 25, 60–70.
   PubMed Web of Science ®Google Scholar
• Marr AK, Gooderham WJ, Hancock RE. (2006). Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol, 6, 468–472.
   PubMed Web of Science ®Google Scholar
• Marshall SH. (2003). Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology. Electronic Journal of Biotechnology, 6 http://www.ejbiotechnology.info/content/vol6/issue3/full/1.
   Web of Science ®Google Scholar
• Matsunaga S, Fusetani N, Konosu S. (1985). Bioactive marine metabolites, IV. Isolation and the amino acid composition of discodermin A, an antimicrobial peptide, from the marine sponge Discodermia kiiensis. J Nat Prod, 48, 236–241.
   Google Scholar
• Matsuzaki K, Harada M, Funakoshi S, Fujii N, Miyajima K. (1991). Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta, 1063, 162–170.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Yoneyama S, Fujii N, Miyajima K, Yamada K, Kirino Y, Anzai K. (1997). Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry, 36, 9799–9806.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. (1999). Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta, 1462, 1–10.
   PubMed Web of Science ®Google Scholar
• McDermott AM. (2009). The role of antimicrobial peptides at the ocular surface. Ophthalmic Res, 41, 60–75.
   PubMed Web of Science ®Google Scholar
• Mecke A, Lee DK, Ramamoorthy A, Orr BG, Banaszak Holl MM. (2005). Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys J, 89, 4043–4050.
   PubMed Web of Science ®Google Scholar
• Mehrnejad F, Naderi-Manesh H, Ranjbar B, Maroufi B, Asoodeh A, Doustdar F. (2008). PCR-based gene synthesis, molecular cloning, high level expression, purification, and characterization of novel antimicrobial peptide, brevinin-2R, in Escherichia coli. Appl Biochem Biotechnol, 149, 109–118.
   PubMed Web of Science ®Google Scholar
• Melo MN, Ferre R, Castanho MA. (2009). Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol, 7, 245–250.
   PubMed Web of Science ®Google Scholar
• Meyer-Hoffert U, Schwarz T, Schroder JM, Glaser R. (2010). Increased expression of human beta-defensin 3 in mollusca contagiosum. Clin Exp Dermatol, 35, 190–192.
   PubMed Web of Science ®Google Scholar
• Mihajlovic M, Lazaridis T. (2010a). Antimicrobial peptides bind more strongly to membrane pores. Biochim Biophys Acta, 1798, 1494–1502.
   PubMed Web of Science ®Google Scholar
• Mihajlovic M, Lazaridis T. (2010b). Antimicrobial peptides in toroidal and cylindrical pores. Biochim Biophys Acta, 1798, 1485–1493.
   PubMed Web of Science ®Google Scholar
• Miyashita M, Sakai A, Matsushita N, Hanai Y, Nakagawa Y, Miyagawa H. (2010). A novel amphipathic linear peptide with both insect toxicity and antimicrobial activity from the venom of the scorpion Isometrus maculatus. Biosci Biotechnol Biochem, 74, 364–369.
   PubMed Web of Science ®Google Scholar
• Mohammed R, Peng J, Kelly M, Hamann MT. (2006). Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. J Nat Prod, 69, 1739–1744.
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Hancock RE. (2007). Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci, 64, 922–933.
   PubMed Web of Science ®Google Scholar
• Moon JY, Henzler-Wildman KA, Ramamoorthy A. (2006). Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim Biophys Acta, 1758, 1351–1358.
   PubMed Web of Science ®Google Scholar
• Moon KE, Gorski JP, Hugli TE. (1981). Complete primary structure of human C4a anaphylatoxin. J Biol Chem, 256, 8685–8692.
   PubMed Web of Science ®Google Scholar
• Mueller GP, Driscoll WJ. (2008). alpha-Amidated peptides: approaches for analysis. Methods Mol Biol, 446, 67–84.
   PubMedGoogle Scholar
• Murakami Y, Takeshita T, Shizukuishi S, Tsunemitsu A, Aimoto S. (1990). Inhibitory effects of synthetic histidine-rich peptides on haemagglutination by Bacteroides gingivalis 381. Arch Oral Biol, 35, 775–777.
   PubMed Web of Science ®Google Scholar
• Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, Ludvigsen S, Raventos D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jorgensen SG, Sorensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH. (2005). Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature, 437, 975–980.
   PubMed Web of Science ®Google Scholar
• Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. (2001). Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol, 167, 3329–3338.
   PubMed Web of Science ®Google Scholar
• Nair DG, Fry BG, Alewood P, Kumar PP, Kini RM. (2007). Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem J, 402, 93–104.
   PubMed Web of Science ®Google Scholar
• Namjoshi S, Caccetta R, Benson HA. (2008). Skin peptides: biological activity and therapeutic opportunities. J Pharm Sci, 97, 2524–2542.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Miller WL, McDermott AM. (2003). Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci, 44, 3795–3801.
   PubMed Web of Science ®Google Scholar
• Naurato N, Wong P, Lu Y, Wroblewski K, Bennick A. (1999). Interaction of tannin with human salivary histatins. J Agric Food Chem, 47, 2229–2234.
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Schibli DJ, Vogel HJ. (2005). Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. J Pept Sci, 11, 379–389.
   PubMed Web of Science ®Google Scholar
• Nijnik A, Hancock RE. (2009). The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol, 16, 41–47.
   PubMed Web of Science ®Google Scholar
• Niyonsaba F, Nagaoka I, Ogawa H. (2006). Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol, 26, 545–576.
   PubMed Web of Science ®Google Scholar
• Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. (2007). Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol, 127, 594–604.
   PubMed Web of Science ®Google Scholar
• Nizet V. (2006). Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol, 8, 11–26.
   PubMed Web of Science ®Google Scholar
• Nizet V. (2007). Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol, 120, 13–22.
   PubMed Web of Science ®Google Scholar
• Noga EJ, Silphaduang U. (2003). Piscidins: a novel family of peptide antibiotics from fish. Drug News Perspect, 16, 87–92.
   PubMedGoogle Scholar
• Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Malmsten M, Björck L, Schmidtchen A. (2004). Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A, 101, 16879–16884.
   PubMed Web of Science ®Google Scholar
• Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A. (2005). Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem, 280, 34832–34839.
   PubMed Web of Science ®Google Scholar
• Nyberg P, Rasmussen M, Bjorck L. (2004). alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem, 279, 52820–52823.
   PubMed Web of Science ®Google Scholar
• Ohlsen K, Dandekar G, Schwarz R, Dandekar T. (2008). New trends in pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics, 9, 1711–1723.
   PubMed Web of Science ®Google Scholar
• Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, Oellig C, Björk I, Claesson-Welsh L. (2004). A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res, 64, 599–605.
   PubMed Web of Science ®Google Scholar
• Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem, 263, 7472–7477.
   Google Scholar
• Oren Z, Hong J, Shai Y. (1997). A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J Biol Chem, 272, 14643–14649.
   PubMed Web of Science ®Google Scholar
• Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J. (2001). Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. J Biol Chem, 276, 17823–17829.
   PubMed Web of Science ®Google Scholar
• Ostberg N, Kaznessis Y. (2005). Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides, 26, 197–206.
   PubMed Web of Science ®Google Scholar
• Ostresh JM, Blondelle SE, Dorner B, Houghten RA. (1996). Generation and use of nonsupport-bound peptide and peptidomimetic combinatorial libraries. Methods Enzymol, 267, 220–234.
   PubMed Web of Science ®Google Scholar
• Otto M. (2006). Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol, 306, 251–258.
   PubMed Web of Science ®Google Scholar
• Otvos L, Jr., O I, Rogers ME, Consolvo PJ, Condie BA, Lovas S, Bulet P, Blaszczyk-Thurin M. (2000). Interaction between heat shock proteins and antimicrobial peptides. Biochemistry, 39, 14150–14159.
   PubMed Web of Science ®Google Scholar
• Oudhoff MJ, Bolscher JG, Nazmi K, Kalay H, van ‘,t Hof W, Amerongen AV, Veerman EC. (2008). Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. Faseb J, 22, 3805–3812.
   PubMed Web of Science ®Google Scholar
• Ovchinnikova TV, Balandin SV, Aleshina GM, Tagaev AA, Leonova YF, Krasnodembsky ED, Men’shenin AV, Kokryakov VN. (2006). Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins. Biochem Biophys Res Commun, 348, 514–523.
   PubMed Web of Science ®Google Scholar
• Pan W, Liu X, Ge F, Han J, Zheng T. (2004). Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. J Biochem, 135, 297–304.
   PubMed Web of Science ®Google Scholar
• Panavas T, Sanders C, Butt TR. (2009). SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. Methods Mol Biol, 497, 303–317.
   PubMedGoogle Scholar
• Papanastasiou EA, Hua Q, Sandouk A, Son UH, Christenson AJ, Van Hoek ML, Bishop BM. (2009). Role of acetylation and charge in antimicrobial peptides based on human beta-defensin-3. APMIS, 117, 492–499.
   PubMed Web of Science ®Google Scholar
• Papareddy P, Kalle M, Kasetty G, Morgelin M, Rydengard V, Albiger B, Lundqvist K, Malmsten M, Schmidtchen A. (2010a). C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules. J Biol Chem, 285, 28387–28398.
   PubMed Web of Science ®Google Scholar
• Papareddy P, Rydengard V, Pasupuleti M, Walse B, Morgelin M, Chalupka A, Malmsten M, Schmidtchen A. (2010b). Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog, 6, e1000857.
   PubMed Web of Science ®Google Scholar
• Park CB, Kim HS, Kim SC. (1998). Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun, 244, 253–257.
   PubMed Web of Science ®Google Scholar
• Park IY, Cho JH, Kim KS, Kim YB, Kim MS, Kim SC. (2004). Helix stability confers salt resistance upon helical antimicrobial peptides. J Biol Chem, 279, 13896–901.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Walse B, Nordahl EA, Morgelin M, Malmsten M, Schmidtchen A. (2007). Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem, 282, 2520–2528.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A. (2008). Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry, 47, 9057–9070.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Chalupka A, Morgelin M, Schmidtchen A, Malmsten M. (2009a). Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. Biochim Biophys Acta, 1790, 800–808.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Davoudi M, Malmsten M, Schmidtchen A. (2009b). Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase. BMC Res Notes, 2, 136.
   PubMedGoogle Scholar
• Pasupuleti M, Roupe M, Rydengard V, Surewicz K, Surewicz WK, Chalupka A, Malmsten M, Sorensen OE, Schmidtchen A. (2009c). Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS ONE, 4, e7358.
   Web of Science ®Google Scholar
• Pasupuleti M, Schmidtchen A, Chalupka A, Ringstad L, Malmsten M. (2009d). End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One, 4, e5285.
   Web of Science ®Google Scholar
• Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RE. (2002). Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother, 46, 605–614.
   PubMed Web of Science ®Google Scholar
• Perron GG, Zasloff M, Bell G. (2006). Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci, 273, 251–256.
   PubMed Web of Science ®Google Scholar
• Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. (2001). Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med, 193, 1067–1076.
   PubMed Web of Science ®Google Scholar
• Peschel A. (2002). How do bacteria resist human antimicrobial peptides? Trends Microbiol, 10, 179–186.
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl HG. (2006). The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol, 4, 529–536.
   PubMed Web of Science ®Google Scholar
• Peters T Jr. (1985). Serum albumin. Adv Protein Chem, 37, 161–245.
   PubMedGoogle Scholar
• Pokorny A, Almeida PF. (2004). Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. Biochemistry, 43, 8846–8857.
   PubMed Web of Science ®Google Scholar
• Potempa J, Pike RN. (2009). Corruption of innate immunity by bacterial proteases. J Innate Immun, 1, 70–87.
   PubMed Web of Science ®Google Scholar
• Powers JP, Hancock RE. (2003). The relationship between peptide structure and antibacterial activity. Peptides, 24, 1681–1691.
   PubMed Web of Science ®Google Scholar
• Pranting M, Negrea A, Rhen M, Andersson DI. (2008). Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Chemother, 52, 2734–2741.
   Google Scholar
• Pranting M, Andersson DI. (2010). Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2. J Antimicrob Chemother, 65, 876–887.
   PubMed Web of Science ®Google Scholar
• Prasad R, Ghannoum AM. (1996). Lipids of Pathogenic Fungi CRC press
   Google Scholar
• Qian S, Wang W, Yang L, Huang HW. (2008). Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. Biophys J, 94, 3512–3522.
   PubMed Web of Science ®Google Scholar
• Qing G, Ma LC, Khorchid A, Swapna GV, Mal TK, Takayama MM, Xia B, Phadtare S, Ke H, Acton T, Montelione GT, Ikura M, Inouye M. (2004). Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol, 22, 877–882.
   PubMed Web of Science ®Google Scholar
• Qu XD, Harwig SS, Shafer WM, Lehrer RI. (1997). Protegrin structure and activity against Neisseria gonorrhoeae. Infect Immun, 65, 636–639.
   PubMed Web of Science ®Google Scholar
• Rao AG. (1999). Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Arch Biochem Biophys, 361, 127–34.
   PubMed Web of Science ®Google Scholar
• Rapaport D, Shai Y. (1991). Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J Biol Chem, 266, 23769–23775.
   PubMed Web of Science ®Google Scholar
• Rasmussen PB, Bjorn S, Hastrup S, Nielsen PF, Norris K, Thim L, Wiberg FC, Flodgaard H. (1996). Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes. FEBS Lett, 390, 109–112.
   PubMed Web of Science ®Google Scholar
• Reddy KV, Yedery RD, Aranha C. (2004). Antimicrobial peptides: premises and promises. Int J Antimicrob Agents, 24, 536–547.
   PubMed Web of Science ®Google Scholar
• Renye JA, Jr., Somkuti GA. (2008). Cloning of milk-derived bioactive peptides in Streptococcus thermophilus. Biotechnol Lett, 30, 723–730.
   PubMed Web of Science ®Google Scholar
• Rijnkels M, Elnitski L, Miller W, Rosen JM. (2003). Multispecies comparative analysis of a mammalian-specific genomic domain encoding secretory proteins. Genomics, 82, 417–432.
   PubMed Web of Science ®Google Scholar
• Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M. (2007). Composition Effect on Peptide Interaction with Lipids and Bacteria: Variants of C3a Peptide CNY21. Biophys J, 92, 87–98.
   PubMed Web of Science ®Google Scholar
• Ringstad L, Protopapa E, Lindholm-Sethson B, Schmidtchen A, Nelson A, Malmsten M. (2008). An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir, 24, 208–216.
   PubMed Web of Science ®Google Scholar
• Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL, Aguilar-Leon D, Torres M, Sada E. (2008). Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun, 76, 935–941.
   PubMed Web of Science ®Google Scholar
• Rodrigues EG, Dobroff AS, Taborda CP, Travassos LR. (2009). Antifungal and antitumor models of bioactive protective peptides. An Acad Bras Cienc, 81, 503–520.
   PubMed Web of Science ®Google Scholar
• Rodziewicz-Motowidlo S, Mickiewicz B, Greber K, Sikorska E, Szultka L, Kamysz E, Kamysz W. (2010). Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide. Febs J, 277, 1010–1022.
   PubMed Web of Science ®Google Scholar
• Rosenfeld Y, Barra D, Simmaco M, Shai Y, Mangoni ML. (2006). A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J Biol Chem, 281, 28565–28574.
   PubMed Web of Science ®Google Scholar
• Rothstein DM, Spacciapoli P, Tran LT, Xu T, Roberts FD, Dalla Serra M, Buxton DK, Oppenheim FG, Friden P. (2001). Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother, 45, 1367–1373.
   PubMed Web of Science ®Google Scholar
• Rozek A, Powers JP, Friedrich CL, Hancock RE. (2003). Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry, 42, 14130–14138.
   PubMed Web of Science ®Google Scholar
• Rydengard V, Olsson AK, Morgelin M, Schmidtchen A. (2007). Histidine-rich glycoprotein exerts antibacterial activity. Febs J, 274, 377–389.
   PubMed Web of Science ®Google Scholar
• Rydengard V, Shannon O, Lundqvist K, Kacprzyk L, Chalupka A, Olsson AK, Morgelin M, Jahnen-Dechent W, Malmsten M, Schmidtchen A. (2008). Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog, 4, e1000116.
   PubMed Web of Science ®Google Scholar
• Sabatini LM, Azen EA. (1989). Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2). Biochem Biophys Res Commun, 160, 495–502.
   PubMed Web of Science ®Google Scholar
• Sabatini LM, Warner TF, Saitoh E, Azen EA. (1989). Tissue distribution of RNAs for cystatins, histatins, statherin, and proline-rich salivary proteins in humans and macaques. J Dent Res, 68, 1138–1145.
   PubMed Web of Science ®Google Scholar
• Saito T, Kawabata S, Shigenaga T, Takayenoki Y, Cho J, Nakajima H, Hirata M, Iwanaga S. (1995). A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity. J Biochem, 117, 1131–1137.
   PubMed Web of Science ®Google Scholar
• Salyers AA, Amabile-Cuevas CF. (1997). Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother, 41, 2321–2325.
   PubMed Web of Science ®Google Scholar
• Sambhara S, Lehrer RI. (2007). The innate immune system: a repository for future drugs? Expert Rev Anti Infect Ther, 5, 1–5.
   PubMed Web of Science ®Google Scholar
• Sansom MS. (1993). Alamethicin and related peptaibols–model ion channels. Eur Biophys J, 22, 105–124.
   PubMed Web of Science ®Google Scholar
• Sawa T, Kurahashi K, Ohara M, Gropper MA, Doshi V, Larrick JW, Wiener-Kronish JP. (1998). Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob Agents Chemother, 42, 3269–3275.
   PubMed Web of Science ®Google Scholar
• Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C. (2001). Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol, 2, 1133–1137.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Frick IM, Björck L. (2001a). Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol, 39, 708–713.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Wolff H, Hansson C. (2001b). Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol, 81, 406–409.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol, 46, 157–168.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Holst E, Tapper H, Bjorck L. (2003). Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb Pathog, 34, 47–55.
   PubMed Web of Science ®Google Scholar
• Schmidtchen A, Pasupuleti M, Morgelin M, Davoudi M, Alenfall J, Chalupka A, Malmsten M. (2009). Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J Biol Chem, 284, 17584–17594.
   PubMed Web of Science ®Google Scholar
• Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. (2005). Human defensins. J Mol Med, 83, 587–595.
   PubMed Web of Science ®Google Scholar
• Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr. (2002). Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A, 99, 2129–2133.
   PubMed Web of Science ®Google Scholar
• Schweizer F. (2009). Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol, 625, 190–194.
   PubMed Web of Science ®Google Scholar
• Scott MG, Hancock RE. (2000). Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol, 20, 407–431.
   PubMed Web of Science ®Google Scholar
• Scott MG, Rosenberger CM, Gold MR, Finlay BB, Hancock RE. (2000a). An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J Immunol, 165, 3358–3365.
   PubMed Web of Science ®Google Scholar
• Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR. (2000b). Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol, 164, 549–553.
   PubMed Web of Science ®Google Scholar
• Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. (2002). The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol, 169, 3883–3891.
   PubMed Web of Science ®Google Scholar
• Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. (1985). Primary structures of three human neutrophil defensins. J Clin Invest, 76, 1436–1439.
   PubMed Web of Science ®Google Scholar
• Selsted ME, Ouellette AJ. (2005). Mammalian defensins in the antimicrobial immune response. Nat Immunol, 6, 551–557.
   PubMed Web of Science ®Google Scholar
• Sewald N, Jakubke HD. (2002). Peptides: Chemistry and Biology edn First Edition: Wiley-VCH.
   Google Scholar
• Shafer WM, Bowdish D, Davidson D, Hancock R. (2006). Immunomodulatory Properties of Defensins and Cathelicidins. In: Shafer WM, ed. Antimicrobial Peptides and Human Disease. Berlin Heidelberg: Springer, 27–66.
   Google Scholar
• Shai Y. (2002). Mode of action of membrane active antimicrobial peptides. Biopolymers, 66, 236–248.
   PubMed Web of Science ®Google Scholar
• Shaykhiev R, Beisswenger C, Kandler K, Senske J, Puchner A, Damm T, Behr J, Bals R. (2005). Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol, 289, L842–848.
   PubMed Web of Science ®Google Scholar
• Shen Y, Ai HX, Song R, Liang ZN, Li JF, Zhang SQ. (2010). Expression and purification of moricin CM4 and human beta-defensins 4 in Escherichia coli using a new technology. Microbiol Res, 165, 713–718.
   PubMedGoogle Scholar
• Shiomi K, Nakazato M, Ihi T, Kangawa K, Matsuo H, Matsukura S. (1993). Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun, 195, 1336–1344.
   PubMed Web of Science ®Google Scholar
• Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J. (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother, 48, 4673–4679.
   PubMed Web of Science ®Google Scholar
• Silvestro L, Gupta K, Weiser JN, Axelsen PH. (1997). The concentration-dependent membrane activity of cecropin A. Biochemistry, 36, 11452–11460.
   PubMed Web of Science ®Google Scholar
• Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB Jr. (1998). Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA, 95, 14961–14966.
   PubMed Web of Science ®Google Scholar
• Singh PK, Tack BF, McCray PB, Jr., Welsh MJ. (2000). Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol, 279, L799–805.
   PubMed Web of Science ®Google Scholar
• Sitaram N, Nagaraj R. (1999). Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta, 1462, 29–54.
   PubMed Web of Science ®Google Scholar
• Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. (1996). Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem, 271, 28375–28381.
   PubMed Web of Science ®Google Scholar
• Solstad T, Larsen AN, Seppola M, Jorgensen TO. (2008). Identification, cloning and expression analysis of a hepcidin cDNA of the Atlantic cod (Gadus morhua L.). Fish Shellfish Immunol, 25, 298–310.
   PubMed Web of Science ®Google Scholar
• Sorensen OE, Gram L, Johnsen AH, Andersson E, Bangsboll S, Tjabringa GS, Hiemstra PS, Malm J, Egesten A, Borregaard N. (2003). Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem, 278, 28540–28546.
   PubMed Web of Science ®Google Scholar
• Sorensen OE, Borregaard N, Cole AM. (2008). Antimicrobial peptides in innate immune responses. Contrib Microbiol, 15, 61–77.
   PubMedGoogle Scholar
• Sörensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood, 97, 3951–3959.
   PubMed Web of Science ®Google Scholar
• Sparkes RS, Kronenberg M, Heinzmann C, Daher KA, Klisak I, Ganz T, Mohandas T. (1989). Assignment of defensin gene(s) to human chromosome 8p23. Genomics, 5, 240–244.
   PubMed Web of Science ®Google Scholar
• Steiner H, Hultmark D, Engström A, Bennich H, Boman HG. (1981). Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature, 292, 246–248.
   PubMed Web of Science ®Google Scholar
• Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M. (2009). Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother, 53, 593–602.
   PubMed Web of Science ®Google Scholar
• Subbalakshmi C, Sitaram N. (1998). Mechanism of antimicrobial action of indolicidin. FEMS Microbiol Lett, 160, 91–96.
   PubMed Web of Science ®Google Scholar
• Sugiarto H, Yu PL. (2006). Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins. Int J Antimicrob Agents, 27, 229–235.
   PubMed Web of Science ®Google Scholar
• Sugiyama K. (1993). Anti-lipopolysaccharide activity of histatins, peptides from human saliva. Experientia, 49, 1095–1097.
   PubMedGoogle Scholar
• Swaminathan GJ, Myszka DG, Katsamba PS, Ohnuki LE, Gleich GJ, Acharya KR. (2005). Eosinophil-granule major basic protein, a C-type lectin, binds heparin. Biochemistry, 44, 14152–14158.
   PubMed Web of Science ®Google Scholar
• Taboureau O, Olsen OH, Nielsen JD, Raventos D, Mygind PH, Kristensen HH. (2006). Design of novispirin antimicrobial peptides by quantitative structure-activity relationship. Chem Biol Drug Des, 68, 48–57.
   PubMed Web of Science ®Google Scholar
• Takahashi D, Shukla SK, Prakash O, Zhang G. (2010). Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie, 92, 1236–1241.
   PubMed Web of Science ®Google Scholar
• Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N. (1995). Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem Pharm Bull (Tokyo), 43, 853–858.
   PubMed Web of Science ®Google Scholar
• Tang YQ, Yuan J, Miller CJ, Selsted ME. (1999). Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes. Infect Immun, 67, 6139–6144.
   PubMed Web of Science ®Google Scholar
• Tasiemski A, Schikorski D, Le Marrec-Croq F, Pontoire-Van Camp C, Boidin-Wichlacz C, Sautiere PE. (2007). Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor. Dev Comp Immunol, 31, 749–762.
   PubMed Web of Science ®Google Scholar
• Territo MC, Ganz T, Selsted ME, Lehrer R. (1989). Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest, 84, 2017–2020.
   PubMed Web of Science ®Google Scholar
• Thomas S, Karnik S, Barai RS, Jayaraman VK, Idicula-Thomas S. (2010). CAMP: a useful resource for research on antimicrobial peptides. Nucleic Acids Res, 38, D774–780.
   PubMed Web of Science ®Google Scholar
• Thomma BP, Cammue BP, Thevissen K. (2002). Plant defensins. Planta, 216, 193–202.
   PubMed Web of Science ®Google Scholar
• Tian C, Gao B, Fang Q, Ye G, Zhu S. (2010). Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective. BMC Genomics, 11, 187.
   PubMed Web of Science ®Google Scholar
• Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, Yahata Y, Dai X, Tohyama M, Nagai H, Yang L, Higashiyama S, Yoshimura A, Sugai M, Hashimoto K. (2005). Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol, 175, 4662–4668.
   PubMed Web of Science ®Google Scholar
• Tomasinsig L, Zanetti M. (2005). The cathelicidins – structure, function and evolution. Curr Protein Pept Sci, 6, 23–34.
   PubMed Web of Science ®Google Scholar
• Torrent M, Andreu D, Nogues VM, Boix E. (2011). Connecting peptide physicochemical and antimicrobial properties by a rational prediction model. PLoS ONE, 6, e16968.
   Web of Science ®Google Scholar
• Tossi A, Scocchi M, Skerlavaj B, Gennaro R. (1994). Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett, 339, 108–112.
   PubMed Web of Science ®Google Scholar
• Tossi A, Sandri L, Giangaspero A. (2000). Amphipathic, alpha-helical antimicrobial peptides. Biopolymers, 55, 4–30.
   PubMed Web of Science ®Google Scholar
• Tran D, Tran P, Roberts K, Osapay G, Schaal J, Ouellette A, Selsted ME. (2008). Microbicidal properties and cytocidal selectivity of Rhesus macaque theta defensins. Antimicrob Agents Chemother, 52, 944–953.
   PubMed Web of Science ®Google Scholar
• Tsai H, Bobek LA. (1998). Human salivary histatins: promising anti-fungal therapeutic agents. Crit Rev Oral Biol Med, 9, 480–497.
   PubMedGoogle Scholar
• Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother, 42, 2206–2214.
   PubMed Web of Science ®Google Scholar
• Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, Segrest JP. (1995). Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry, 34, 4393–4401.
   PubMed Web of Science ®Google Scholar
• Uematsu N, Matsuzaki K. (2000). Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study. Biophys J, 79, 2075–2083.
   PubMed Web of Science ®Google Scholar
• Ueno S, Kusaka K, Tamada Y, Zhang H, Minaba M, Kato Y. (2010). An enhancer peptide for membrane-disrupting antimicrobial peptides. BMC Microbiol, 10, 46.
   PubMed Web of Science ®Google Scholar
• Ullal AJ, Litaker RW, Noga EJ. (2008). Antimicrobial peptides derived from hemoglobin are expressed in epithelium of channel catfish (Ictalurus punctatus, Rafinesque). Dev Comp Immunol, 32, 1301–1312.
   PubMed Web of Science ®Google Scholar
• Uteng M, Hauge HH, Markwick PR, Fimland G, Mantzilas D, Nissen-Meyer J, Muhle-Goll C. (2003). Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge. Biochemistry, 42, 11417–11426.
   PubMed Web of Science ®Google Scholar
• Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. (1991). Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res, 51, 3062–3066.
   PubMed Web of Science ®Google Scholar
• Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M. (2003). Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides, 24, 1655–1667.
   PubMed Web of Science ®Google Scholar
• Valenti P, Antonini G. (2005). Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci, 62, 2576–2587.
   PubMed Web of Science ®Google Scholar
• van’t Hof W, Veerman EC, Helmerhorst EJ, Amerongen AV. (2001). Antimicrobial peptides: properties and applicability. Biol Chem, 382, 597–619.
   PubMed Web of Science ®Google Scholar
• van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW. (2000). Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood, 96, 176–181.
   PubMed Web of Science ®Google Scholar
• van Dijk A, Veldhuizen EJ, van Asten AJ, Haagsman HP. (2005). CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Vet Immunol Immunopathol, 106, 321–327.
   PubMed Web of Science ®Google Scholar
• Viejo-Diaz M, Andres MT, Fierro JF. (2005). Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. Antimicrob Agents Chemother, 49, 2583–2588.
   PubMed Web of Science ®Google Scholar
• Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. (2004a). A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem, 279, 54881–54886.
   PubMed Web of Science ®Google Scholar
• Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M. (2004b). Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol, 6, 269–275.
   PubMed Web of Science ®Google Scholar
• Wang G, Li X, Wang Z. (2009a). APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res, 37, D933–937.
   PubMed Web of Science ®Google Scholar
• Wang P, Bang JK, Kim HJ, Kim JK, Kim Y, Shin SY. (2009b). Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1. Peptides, 30, 2144–2149.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R. (2008). Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS ONE, 3, e3217.
   Web of Science ®Google Scholar
• Wang Z, Wang G. (2004). APD: the Antimicrobial Peptide Database. Nucleic Acids Res, 32, D590–592.
   PubMed Web of Science ®Google Scholar
• Welling MM, Hiemstra PS, van den Barselaar MT, Paulusma-Annema A, Nibbering PH, Pauwels EK, Calame W. (1998). Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest, 102, 1583–1590.
   PubMed Web of Science ®Google Scholar
• Wessolowski A, Bienert M, Dathe M. (2004). Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization. J Pept Res, 64, 159–169.
   PubMedGoogle Scholar
• Wieprecht T, Dathe M, Epand RM, Beyermann M, Krause E, Maloy WL, MacDonald DL, Bienert M. (1997). Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry, 36, 12869–12880.
   PubMed Web of Science ®Google Scholar
• Wiesner J, Vilcinskas A. (2010). Antimicrobial peptides: the ancient arm of the human immune system. Virulence, 1, 440–464.
   PubMed Web of Science ®Google Scholar
• Willey JM, van der Donk WA. (2007). Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol, 61, 477–501.
   PubMed Web of Science ®Google Scholar
• Wu Y, He K, Ludtke SJ, Huang HW. (1995). X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys J, 68, 2361–2369.
   PubMed Web of Science ®Google Scholar
• Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, Oppenheim JJ, Lubkowski J, Lu W. (2003). Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A, 100, 8880–8885.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G. (2006). Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem, 281, 2858–2867.
   PubMed Web of Science ®Google Scholar
• Xu L, Lal K, Pollock JJ. (1992). Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva. Oral Microbiol Immunol, 7, 127–128.
   PubMedGoogle Scholar
• Yan Q, Bennick A. (1995). Identification of histatins as tannin-binding proteins in human saliva. Biochem J, 311 (Pt 1), 341–347.
   PubMedGoogle Scholar
• Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. (2004a). Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol, 22, 181–215.
   PubMed Web of Science ®Google Scholar
• Yang L, Weiss TM, Lehrer RI, Huang HW. (2000). Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J, 79, 2002–2009.
   PubMed Web of Science ®Google Scholar
• Yang WH, Zhang WC, Lu XM, Jiang GS, Gao PJ. (2009). Characterization of a novel antibacterial glycopeptide produced by Penicillium sp. M03. Lett Appl Microbiol, 48, 393–397.
   PubMed Web of Science ®Google Scholar
• Yang YH, Zheng GG, Li G, Zhang XJ, Cao ZY, Rao Q, Wu KF. (2004b). Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein Expr Purif, 37, 229–235.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev, 55, 27–55.
   PubMed Web of Science ®Google Scholar
• Yount NY, Yeaman MR. (2005). Immunocontinuum: perspectives in antimicrobial peptide mechanisms of action and resistance. Protein Pept Lett, 12, 49–67.
   PubMed Web of Science ®Google Scholar
• Yount NY, Bayer AS, Xiong YQ, Yeaman MR. (2006). Advances in antimicrobial peptide immunobiology. Biopolymers, 84, 435–458.
   Google Scholar
• Yount NY, Yeaman MR. (2006). Structural congruence among membrane-active host defense polypeptides of diverse phylogeny. Biochim Biophys Acta, 1758, 1373–1386.
   PubMed Web of Science ®Google Scholar
• Zanetti M, Gennaro R, Romeo D. (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett, 374, 1–5.
   PubMed Web of Science ®Google Scholar
• Zanetti M. (2004). Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol, 75, 39–48.
   PubMed Web of Science ®Google Scholar
• Zasloff M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A, 84, 5449–5453.
   PubMed Web of Science ®Google Scholar
• Zasloff M. (1992). Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol, 4, 3–7.
   PubMed Web of Science ®Google Scholar
• Zasloff M. (2002). Antimicrobial peptides of multicellular organisms. Nature, 415, 389–395.
   PubMed Web of Science ®Google Scholar
• Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A. (2006). Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J Biol Chem, 281, 19861–19871.
   Google Scholar
• Zeya HI, Spitznagel JK. (1963). Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification. Science, 142, 1085–7.
   PubMed Web of Science ®Google Scholar
• Zeya HI, Spitznagel JK. (1966). Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities. J Bacteriol, 91, 750–754.
   Google Scholar
• Zhang J, Dyer KD, Rosenberg HF. (2003). Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res, 31, 602–607.
   PubMed Web of Science ®Google Scholar
• Zhang L, Scott MG, Yan H, Mayer LD, Hancock RE. (2000). Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry, 39, 14504–14514.
   PubMed Web of Science ®Google Scholar
• Zhang L, Rozek A, Hancock RE. (2001). Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem, 276, 35714–35722.
   PubMed Web of Science ®Google Scholar
• Zhang MQ, Wilkinson B. (2007). Drug discovery beyond the ‘rule-of-five’. Curr Opin Biotechnol, 18, 478–488.
   PubMed Web of Science ®Google Scholar
• Zhao H: Mode of action of antimicrobial peptides [Academic dissertation]. Helsinki: University of Helsinki: 2003.
   Google Scholar
• Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y. (2008). Identification and characterization of novel reptile cathelicidins from elapid snakes. Peptides, 29, 1685–1691.
   PubMed Web of Science ®Google Scholar
• Zipfel PF, Reuter M. (2009). Complement Activation Products C3a and C4a as Endogenous Antimicrobial Peptides. International Journal of Peptide Research and Therapeutics, 15, 87–95.
   Web of Science ®Google Scholar